Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 8:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 1,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ulcerative Clear all

Conditions: Diabetic Foot
Interventions: Revita Allograft; Other
Lead sponsor: StimLabs; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Pensacola, Florida • Lake Charles, Louisiana • Springfield, Pennsylvania

Conditions: Diabetes, Neuropathic Limb, Elevated Temperature, Shear Pressure, Increased Temperatures
Interventions: TempTouchRM, Offloading; Device
Lead sponsor: Diabetica Solutions Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetic Foot Ulcers
Interventions: Gentamicin Topical Gel, Ciprofloxacin, Doxycycline; Drug
Lead sponsor: Royer Biomedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 7
States / cities: Washington D.C., District of Columbia • Miami, Florida • Miami Lakes, Florida + 4 more

Conditions: Pyoderma Gangrenosum
Interventions: Bimekizumab; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Ulcerative Colitis, Crohn's Disease
Interventions: Vedolizumab; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 2,243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 31
States / cities: Birmingham, Alabama • San Diego, California • San Francisco, California + 28 more

Conditions: Ulcerative Colitis, Crohn's Disease
Interventions: Chromoendoscopy with magnification; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Colitis, Ulcerative
Interventions: Vedolizumab; Drug
Lead sponsor: Takeda; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 11
States / cities: Phoenix, Arizona • San Diego, California • Atlanta, Georgia + 8 more

Conditions: Ulcerative Colitis
Interventions: RPC1063; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 877 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 10
States / cities: Tucson, Arizona • Anaheim, California • Mission Hills, California + 7 more

Conditions: Pressure Ulcers
Interventions: Nutritional Supplement/Amino acids and HMB, Juven; Dietary Supplement
Lead sponsor: Central Arkansas Veterans Healthcare System; Federal
Eligibility: 21 Years to 90 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Ulcerative Colitis
Interventions: Oral OKT3, Omeprazole; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Venous Leg Ulcer
Interventions: Cutimed® Sorbact®, Acticoat®; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Ulcerative Colitis
Interventions: adalimumab, placebo; Biological
Lead sponsor: Abbott; Industry
Eligibility: 18 Years and older
Enrollment: 576 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 29
States / cities: Birmingham, Alabama • Mobile, Alabama • Fayetteville, Arkansas + 25 more

Conditions: Diabetic Foot Ulcer
Interventions: Dermal - Living Skin Replacement (Dermal - LSR); Device
Lead sponsor: ApoPharma; Industry
Eligibility: 18 Years to 84 Years
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 12
States / cities: Tuscon, Arizona • Mather, California • San Diego, California + 8 more

Conditions: Esophagitis, Reflux, Esophagitis, Peptic
Interventions: Dexlansoprazole MR, Lansoprazole; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 2,038 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 96
States / cities: Alabaster, Alabama • Birmingham, Alabama • Huntsville, Alabama + 93 more

Conditions: Ulcerative Colitis
Interventions: Low Dose Budesonide, High Dose Budesonide, Placebo; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 5 Years to 17 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Garden Grove, California • Indianapolis, Indiana • The Bronx, New York + 1 more

Conditions: Wound Care, Venous Ulcer Care, Wound Cleansing, Chronic Wound Care
Interventions: Prontosan wound irrigation solution; Device
Lead sponsor: Calvary Hospital, Bronx, NY; Other
Eligibility: 18 Years to 95 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: NSAID-induced Gastroduodenal Injury, Ulcers, Rheumatoid Arthritis, Osteoarthritis
Interventions: Cobiprostone, Placebo, Non-steroidal anti-inflammatory drug; Drug
Lead sponsor: Sucampo Pharma Americas, LLC; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 19
States / cities: Phoenix, Arizona • Chula Vista, California • Loma Linda, California + 16 more

Conditions: Pressure Ulcer
Interventions: Casting using Gortex (waterproof) cast padding materials, Casting using cotton/cotton-poly cast padding materials; Other
Lead sponsor: Shriners Hospitals for Children; Other
Eligibility: 1 Year to 18 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Ulcer, Leg Ulcer, Varicose Ulcer, Pathologic Processes, Skin Ulcer, Skin Diseases, Vascular Diseases, Cardiovascular Diseases
Interventions: Placebo, VF001-DP LD, VF001-DP HD; Biological
Lead sponsor: Factor Therapeutics Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 17
States / cities: Carlsbad, California • Fresno, California • Laguna Hills, California + 10 more

Conditions: Ulcerative Colitis, Crohn's Disease
Interventions: No intervention; Other
Lead sponsor: Takeda; Industry
Eligibility: 65 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Foot Ulcer, Diabetic
Interventions: GrafixPRIME®, Dressing Application, Off-loading (walking boot); Other · Procedure · Device
Lead sponsor: Osiris Therapeutics; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Arizona City, Arizona • California City, California • New Mexico, New Mexico

Conditions: Ulcerative Colitis
Interventions: Cobitolimod 250 mg, Cobitolimod 500 mg, Placebo; Drug
Lead sponsor: InDex Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 25
States / cities: Granada Hills, California • Mission Viejo, California • Rancho Cucamonga, California + 17 more

Conditions: Crohn's Disease, Ulcerative Colitis, Inflammatory Bowel Disease
Interventions: Vedolizumab; Drug
Lead sponsor: Shaare Zedek Medical Center; Other
Eligibility: Up to 18 Years
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 4
States / cities: Hartford, Connecticut • Morristown, New Jersey • New York, New York + 1 more

Conditions: Gastroduodenal Ulcer
Interventions: Naproxen, Aspirin, Celecoxib, Clopidogrel, Placebo; Drug
Lead sponsor: Research Associates of New York, LLP; Other
Eligibility: 18 Years to 75 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Efficacy of Human Placental Graft in Diabetic Foot Ulcers

Novel Home Care Device for High-Risk Diabetic Patients

Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers

Efficacy of Bimekizumab in Adults With Pyoderma Gangrenosum

An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease

Chromoendoscopy for Ulcerative Colitis Surveillance

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)

An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)

Oral OKT3 for the Treatment of Active Ulcerative Colitis

VLU Dressing Study

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis

Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Effect of Prontosan Wound Irrigation Solution on Venous Ulcers

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

Cast Sores With Waterproof Vs. Standard Cast Padding

Study of VF001-DP in Patients With Chronic Venous Leg Ulcers

A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease

GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers

The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases

Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers